NCT06837220 Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites
| NCT ID | NCT06837220 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Nicotine Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2026-07-20 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2026-07-20 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.
Eligibility Criteria
Inclusion Criteria: * Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month * Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting) * Age 18 or older, ability to understand the English language, willing and able to provide informed consent * Stable residence and contact information throughout the follow up period Exclusion Criteria: * Non-daily or intermittent cigarette use * No interest in quitting smoking * Unstable residence/not staying in Chicago for duration of study period * Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06837220 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 26 Years, studying Nicotine Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06837220 currently recruiting?
Yes, NCT06837220 is actively recruiting participants. Contact the research team at ebrett@bsd.uchicago.edu for enrollment information.
Where is the NCT06837220 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06837220 clinical trial?
NCT06837220 is sponsored by University of Chicago. The trial plans to enroll 24 participants.